Rate My Professor Amanda Cox

Dr. Amanda Cox is a Senior Lecturer in the School of Pharmacy and Medical Sciences at Griffith University, where she serves as one of the academic leads for the Central Facility for Genomics and the Mucosal Immunology Research Group. Holding a Bachelor of Biomedical Science (BBiomedSci) and a PhD, her research career centers on applied mucosal immunology, with a particular emphasis on the role of the microbiota in modulating immune responses at mucosal sites such as the airways and gastrointestinal tract. Cox has conducted extensive studies on probiotics, investigating their survival and recovery in the human gut following supplementation. Notable work includes demonstrating the recoverability of Lactobacillus casei strain Shirota from feces after 14 days of fermented milk intake in healthy adults (2019) and evaluating a multispecies probiotic supplement's efficacy in relieving seasonal allergic rhinitis symptoms through a randomized double-blind placebo-controlled trial (2023). Additional research explores immunomodulatory effects of fucoidan in recreationally active males (2023), impacts of faecal subsampling on microbial analysis (2022), and gut microbiome influences on metabolic and immune indices in males (2024). Her contributions extend to spatial multi-omics characterization in neuroblastoma (2026) and molecular analysis of tick-bitten skin (2024), highlighting applications in infectious diseases and allergy management. Previously affiliated with the Menzies Health Institute Queensland, Cox's work underscores the potential of microbial interventions in immune-mediated conditions, including hay fever and exercise-induced responses.

Cox's publications reflect her focus on practical immunology applications, including Gut Balance, a synbiotic supplement increasing fecal Lactobacillus species (2012), and studies on probiotic effects during exercise in heat-stressed women (2018). She contributes to advanced techniques like spatial biology and genomics, supporting collaborations in complex disease research. As part of Griffith Health, her efforts advance understanding of host-microbe interactions, informing probiotic use for health benefits in respiratory and gut-related immunity. Her role in facility leadership facilitates cutting-edge genomic technologies for broader biomedical research.